TRPV4 and Sepsis: Alternatively, since plasma osmolality is known to increase in sepsis (Jochbergeret al., 2009), and hypertonicity inhibits TRPV4 activity (Strotmannet al., 2000), it is possible that under septic conditions, TRPV4 activity is inhibited such that gene deletion or pharmacological antagonism will produce no further effect.